Is hantavirus the next COVID? Is the U.S. response on point? An outbreak update

A hantavirus outbreak originating from a cruise ship has resulted in three deaths and eight cases (five confirmed) since early April, according to public health authorities. The first patient, a man who fell ill before boarding the ship, likely contracted the Andes virus strain during birdwatching at a landfill in Ushuaia, Argentina. He and his wife, both passengers, later died from the virus, along with a German woman aboard. The ship’s doctor, also infected, was evacuated to Europe for treatment. The Andes virus is the only known hantavirus strain capable of human-to-human transmission, primarily through close contact with symptomatic individuals. Experts suggest the initial patient spread the virus while asymptomatic, with symptoms—including fever, muscle aches, and respiratory distress—emerging days later. The World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) stress the risk to the general public remains low, despite alarmist headlines. Hantavirus infections typically begin with flu-like symptoms but can progress to severe respiratory illness, carrying a reported 30–40% mortality rate, though experts caution this may be overestimated due to underreporting of mild cases. There is no vaccine or cure; treatment focuses on supportive care, such as ventilator assistance. The WHO notes transmission occurs mainly through prolonged close contact, including among household members or medical staff. The outbreak echoes a 2018–2019 Argentina cluster where the virus spread among birthday party attendees seated nearby. Current investigations aim to clarify transmission patterns, though the WHO’s Maria Van Kerkhove dismissed comparisons to COVID-19, emphasizing the virus’s distinct spread mechanisms. Public health officials urge rapid medical attention for suspected cases to improve survival rates.